跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 91,617 条关于
“Fabry disease cardiomyopathy”
全部
91,617
临床试验
68,866
药物
1,431
机构
179
资讯
21,141
2年前
4DMT's 4D-310 Shows Promising Cardiac Improvements in Fabry Disease Trial
11个月前
EMA Rejects Extended Dosing Regimen for Fabry Disease Treatment Elfabrio
去年
AceLink Therapeutics' AL01211 Shows Promising Safety and Biomarker Reduction in Phase 2 Fabry Disease Trial
去年
Less Frequent Elfabrio Dosing Shows Promise in Fabry Disease
去年
FDA Grants Orphan Drug Designation to EXG110 Gene Therapy for Fabry Disease
去年
Sangamo's Fabry Disease Gene Therapy ST-920 Poised for Accelerated FDA Approval
3个月前
Sangamo's Isaralgagene Civaparvovec Nears Accelerated Approval as Fabry Disease Market Poised to Reach $5.92 Billion by 2035
去年
Serum Neurofilament Light Chain Shows Potential as Fabry Disease Biomarker
8个月前
Lucerastat Demonstrates Significant Efficacy in Phase 3 Trial for Fabry Disease Treatment
去年
AceLink's Oral GCS Inhibitor Shows Promising Phase 2 Results in Fabry Disease Treatment
第 1 页，共 2115 页
上一页
下一页
